Effects of musk xylene and musk ketone on rat hepatic cytochrome P450 enzymes

Chemicals of emerging concern in the Great Lakes Basin: an analysis of environmental exposures

This review and statistical analysis was conducted to better understand the nature and significance of environmental exposures in the Great Lakes Basin and watershed to a variety of environmental contaminants. These contaminants of interest included current-use pesticides, pharmaceuticals, organic wastewater contaminants, alkylphenol ethoxylates, perfluorinated surfactants, flame retardants, and chlorinated paraffins. The available literature was critically reviewed and used to develop a database containing 19,611 residue values for 326 substances. In many papers, sampling locations were characterized as being downstream from municipal wastewater discharges, receiving waters for industrial facilities, areas susceptible to agricultural or urban contamination, or harbors and ports. To develop an initial assessment of their potential ecological significance, the contamination levels found were compared with currently available regulatory standards, guidelines, or criteria. This review was prepared for the IJC multi-board work group, and served as background material for an expert consultation, held in March, 2009, in which the significance of the contaminants found was discussed. Moreover, the consultation attempted to identify and assess opportunities for strengthening future actions that will protect the Great Lakes. Based on the findings and conclusions of the expert consultation, it is apparent that a wide variety of chemicals of emerging concern have been detected in environmental media (air, water, sediment, biota) from the Great Lakes Basin, although many are present at only trace levels. Although the presence of these contaminants raises concerns in the public and among the scientific community, the findings must be placed in context. Significant scientific interpretation is required to understand the extent to which these chemicals may pose a threat to the ecosystem and to human health. The ability to detect chemicals in environmental media greatly surpasses our ability to understand the implications of such findings. As advances in analytical technologies occur, it is probable that substances previously found to be non-detectable will be detected. However, their presence in environmental media should not be construed to mean that they are necessarily toxic or hazardous. Current-use pesticides are tightly regulated and extensive efforts have been made to analyze for their presence in surface waters from the Great Lakes Basin. The concentrations found in surface waters for many of the pesticides are below current regulatory criteria. However, the concentrations of certain pesticides exceeded current criteria in 6-32% of the samples analyzed. Detectable concentrations of pharmaceutical compounds were present in 34% of the surface water samples. Various prescription and non-prescription drugs were detected, most frequently at locations that were proximate to the point of discharge from wastewater treatment plants or agricultural operations. At present, there are no standards, guidelines, or criteria with which to compare these contaminant concentrations. Concentrations of alkylphenol ethoxylates and their metabolites have been well studied. All surface water nonylphenol concentrations were below US ambient water quality criteria. However, the concentrations reported for some locations exceeded Canadian guidelines for water or sediment. Only limited data were available for a wide variety of organic wastewater contaminants. Measured concentrations in Great Lakes waters were generally low. Where criteria exist for comparison, the concentrations found were generally below the associated regulatory standards. However, exceedences were noted for some classes of compounds, including phthalates and polycyclic aromatic hydrocarbons. The highest environmental concentrations were reported in biota for a number of persistent, bioaccumulative, and toxic compounds (e.g., polybrominated diphenyl ethers, perfluorinated surfactants). Various stewardship as well as government risk assessment and risk management programs have been implemented over the past years for many of these compounds. Because risk management strategies for some of these contaminants have been implemented only recently, their impact on environmental concentrations, to date, remains unclear. Current evidence suggests that the concentrations of some brominated flame retardants are trending downward, while the concentrations of others appear to be increasing. Regulatory criteria are not available for many of the chemicals of emerging concern that were detected in the Great Lakes Basin. When criteria do exist, it is important to recognize that they were developed based on the best available science at the time. As the science evolves, regulatory criteria must be reassessed in light of new findings (e.g., consideration of new endpoints and mechanisms of action). Further, there are significant scientific gaps in our ability to interpret environmental monitoring data, including the need for: (a) improving the understanding of the effects of mixtures, (b) information on use of, and the commercial life cycle of chemicals and products that contain them, (c) information on source contributions and exposure pathways, and (d) the need for thoughtful additional regulatory,environmental, and health criteria. Discharges from wastewater treatment plants were identified as an important source of contaminants to surface waters in the Great Lakes Basin. Combined sewer overflows and agricultural operations were also found to be important contributors to concentrations in surface waters. Concentrations of many of the chemicals were generally the highest in the vicinity of these sources, decline with increasing distance from sources, and were generally low or non-detectable in the open waters of the Great Lakes.

Interactions of 2,4,6-trinitrotoluene (TNT) with xenobiotic biotransformation system in European eel Anguilla anguilla (Linnaeus, 1758)

The aim of the present study was to investigate the interaction of 2,4,6-trinitrotoluene (TNT) with liver biotransformation enzymes in European eel Anguilla anguilla (Linnaeus, 1758). Eels were exposed to 0.5, 1 and 2.5mg/l nominal concentrations of TNT for 6 and 24h. Modulation of CYP1A1, UDPGT and GST genes was investigated by real-time PCR. Total CYP450 content, NADPH cytochrome c reductase activity, CYP1A and CYP2B-like activities, such as EROD, MROD and BROD, as well as GST and UDPGT activities, were measured by biochemical assays. An in vitro study was performed on EROD in order to evaluate catalytic modulation by TNT. No modulation of the CYP1A1 gene or protein was observed in TNT-exposed eels. On the other hand, a significant decline of EROD and MROD activities was observed in vivo. An increase in NADPH cyt c reductase, and phase II enzymes (UDPGT and GST) were observed at both gene expression and activity levels. The overall results indicated that TNT is a potential competitive inhibitor of CYP1A activities. A TNT metabolic pathway involving NADPH cyt c reductase and phase II enzymes is also suggested.

On the Mechanism of Hepatocarcinogenesis of Benzodiazepines: Evidence that Diazepam and Oxazepam are CYP2B Inducers in Rats, and both CYP2B and CYP4A Inducers in Mice

The aim of this study was to evaluate diazepam and oxazepam as cytochrome P450 inducers at doses previously shown to cause liver tumors in mice but not rats. In rats, diazepam and oxazepam induced CYP2B, and were as effective as phenobarbital despite lacking phenobarbital's tumor-promoting effect in rats. In mice, diazepam and oxazepam induced both CYP2B and CYP4A at dietary doses associated with liver tumor formation. It remains to be determined why diazepam and oxazepam induce CYP4A in mice but not rats and whether this difference accounts for the apparent species difference in the tumor-promoting activity of diazepam and oxazepam.

The involvement of cytochrome P450 system in the fate of 2,4,6-trinitrotoluene (TNT) in European eel [Anguilla anguilla (Linnaeus, 1758)]

TNT (2,4,6-trinitrotoluene) was the most common nitro aromatic explosive available in World War II ammunitions. The presence of ordnance dumped at sea might represent a great concern for marine species living close to dumping sites and the toxicological properties of the chemicals released into the marine environments need to be evaluated. The aim of the present study is to investigate the involvement of CYP (cytochrome P450) system in the metabolism of TNT in marine organisms by using the European eel [Anguilla anguilla (Linnaeus, 1758)] as model species. In vivo exposure to sublethal concentration of TNT (0.5, 1 and 2.5 mg/l) leads to a significant decrease in the phase I CYP1A catalytic activities such as EROD (7-ethoxyresorufin-O-de-ethylase) and MROD (7-methoxyresorufin-O-de-ethylase). On the opposite, a significant increase in NADPH cytochrome c reductase activity as well as phase II UDP-glucuronosyltransferase activity is observed. An inhibition at enzyme level is hypothesized for both CYP1A enzymes, also confirmed by a similar decrease observed after in vitro exposure. An active role of NADPH cytochrome c reductase and phase II enzymes in the TNT metabolism may also be hypothesized.

The effect of fenbuconazole on cell proliferation and enzyme induction in the liver of female CD1 mice

Fenbuconazole, a triazole fungicide, has been associated with an increase in the incidence of liver adenomas in female mice following long-term dietary exposure. The aim of this study was to evaluate whether the mode of action for liver tumor formation by fenbuconazole is similar to that of phenobarbital. Treatment of CD1 mice with 0, 20, 60, 180 or 1300 ppm fenbuconazole for up to 4 weeks caused a dose-dependent increase in liver weight that was associated with centrilobular hepatocellular hypertrophy, cytoplasmic eosinophilia and panlobular hepatocellular vacuolation, as well as an initial increase in the cell proliferation labeling index. Fenbuconazole also caused a dose-dependent increase in liver microsomal cytochromes b(5) and P450 and the levels of immunoreactive CYP2B10 and its associated activity 7-pentoxyresorufin O-dealkylation (PROD). Treatment of mice with 1000 ppm phenobarbital elicited the same effects as treatment of mice with 1300 ppm fenbuconazole, except that phenobarbital was more effective than fenbuconazole at inducing PROD activity, even though fenbuconazole induced CYP2B10 to the same extent as did phenobarbital. This difference was attributed to the ability of fenbuconazole to bind tightly to CYP2B10 and partially mask its catalytic activity in liver microsomes, which is characteristic of several azole-containing drugs. All hepatocellular changes and induced enzyme activity returned to control levels within 4 weeks of discontinuing treatment with fenbuconazole or phenobarbital, indicating that the observed changes were fully reversible. We conclude that fenbuconazole is a phenobarbital-type inducer of mouse liver cytochrome P450, and the mode of action by which fenbuconazole induces liver adenomas in mice is similar to that of phenobarbital.

Inhibition of larval development of the marine copepod Acartia tonsa by four synthetic musk substances

A nitro musk (musk ketone) and three polycyclic musks (Tonalide, Galaxolide and Celestolide) were tested for acute and subchronic effects on a marine crustacean, the calanoid copepod Acartia tonsa. Sublethal effects on A. tonsa larvae were investigated with a rapid and cost effective bioassay, which is based on the easily detectable morphological change from the last nauplius to the first copepodite stage during copepod larval development. The inhibition of larval development after 5 days exposure was a very sensitive endpoint, with 5-d-EC(50)-values as low as 0.026 mg/l (Tonalide), 0.059 mg/l (Galaxolide), 0.066 mg/l (musk ketone) and 0.160 mg/l (Celestolide), respectively. These values were generally more than one order of magnitude below the 48-h-LC(50)-values found for adults, which were 0.47 mg/l (Galaxolide), 0.71 mg/l (Celestolide), 1.32 mg/l (musk ketone) and 2.5 mg/l (Tonalide). Since the synthetic musks strongly inhibited larval development in A. tonsa at low nominal concentrations, they should be considered as very toxic. The larval development test with A. tonsa is able to provide important aquatic toxicity data for the evaluation of synthetic musks, for which there is little published ecotoxicological information available regarding Crustacea. It is suggested that subchronic and chronic copepod toxicity tests should be used more frequently for risk assessment of environmental pollutants.

Macrocyclic musk compounds—an absence of genotoxicity in the Ames test and the in vivo Micronucleus assay

Three synthetic macrocyclic musks, ethylene dodecanedioate, ethylene brassylate, and cyclopentadecanolide, which are widely used as ingredients of perfume fragrances, were tested for genotoxicity. In this report we present results from two different studies, the flow-cytometer-based micronucleus assay in peripheral blood of mice and the Salmonella/microsome test with TA 97, TA 98, and TA 100. Female NMRI and male CD 1 mice were intraperitoneally injected with one of the three macrocyclic musk compounds. Three different doses (0.1-1.6 g/kg bw) of each of the compounds were tested. Blood samples were collected on two occasions from each mouse and the frequency of micronucleated polychromatic erythrocytes (fMPCE) was determined. Neither of the compounds caused a significant difference from the control fMPCE. No mutagenic effect with and without S9 mix in the tested Salmonella strains was observed. The presence of S9 mix reduced the killing effect of high doses.

Nitromusk compounds in women with gynecological and endocrine dysfunction

Musk xylene (MX), musk ketone (MK), musk ambrette, musk moskene, and musk tibetene are synthetic fragrances. Between 1994 and 1996 these five nitromusk compounds (NMCs) were tested in the blood of 152 women who consulted the Endocrinological Department of the University Hospital of Obstetrics and Gynecology, Heidelberg, Germany, because of gynecological problems. The testing was conducted by gas chromotography with mass-specific detector and mass spectrometry in a retrospective cross-sectional study. MX was detected in 95% and MK in 85% of the blood samples (>20 ng per liter whole blood). The median concentration of MX was 65.5 ng/L and the maximum level of MX was 1183 ng/L; the corresponding values for MK were respectively 55.5 and 518 ng/L. The other three NMCs were found in only a few patients or not at all. Significant associations between MX and MK concentrations were found in blood and different clinical parameters of the endocrine system. MX and MK may act centrally as a disrupter of the (supra-) hypothalamic-ovarian axis, which may result in a mild ovarian insufficiency. On the basis of our data, a reproductive toxicity and an endocrine effect of NMCs in women cannot be ruled out. Further experimental and clinical studies should be conducted.

Evaluation of health risks caused by musk ketone

Among the nitro musks, musk ketone (MK) as a synthetic compound with a typical musk odor is widely used in cosmetics. In the European Community the total amount used in fragrances has been reported to be 110 tons/a. Additionally, relevant amounts of MK are used in Indian joss sticks. As a result of its inherently low biodegradability MK has been detected in the aquatic environment (surface water, sediments, edible fish). Moreover, it has been shown that MK concentrates in human fatty tissue and breast milk, indicating that humans are constantly exposed. Several studies provided convincing evidence of lack of a genotoxic potential for MK. However, MK was identified as a strong inducer of phase I enzymes in rodents and a cogenotoxicant in vitro in human derived cells in rather low doses, suggesting that exposure to MK might increase the susceptibility to health hazards caused by carcinogens in humans.